SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-20-026631
Filing Date
2020-02-06
Accepted
2020-02-06 14:29:55
Documents
1
Group Members
BIOTECH TARGET N.V.

Document Format Files

Seq Description Document Type Size
1 SC 13G d883270dsc13g.htm SC 13G 67672
  Complete submission text file 0001193125-20-026631.txt   69290
Mailing Address SCHWERTSTRASSE 6 SCHAFFHAUSEN V8 8200
Business Address SCHWERTSTRASSE 6 SCHAFFHAUSEN V8 8200 411724 59 59
BB BIOTECH AG (Filed by) CIK: 0000924223 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G
SIC: 0000

Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Subject) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87380 | Film No.: 20582307
SIC: 2834 Pharmaceutical Preparations